Trial Outcomes & Findings for Effect of Increased Light Exposure on Fatigue in Breast Cancer (NCT NCT00478257)

NCT ID: NCT00478257

Last Updated: 2019-02-06

Results Overview

The Short Form of the Multidimensional Fatigue Symptom Inventory (MFSI-sf) was used to measure fatigue. The range of possible score for each subscale is 0 to 24, and the range for total score is -24 to 96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where larger score indicates less fatigue.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

39 participants

Primary outcome timeframe

four cycles of chemotherapy

Results posted on

2019-02-06

Participant Flow

Participant milestones

Participant milestones
Measure
Effect of Bright Light
Effect of bright light on fatigue in women with breast cancer
Effect of Red Light
effect of red light on fatigue in women with breast cancer
Overall Study
STARTED
23
16
Overall Study
COMPLETED
15
13
Overall Study
NOT COMPLETED
8
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Effect of Bright Light
Effect of bright light on fatigue in women with breast cancer
Effect of Red Light
effect of red light on fatigue in women with breast cancer
Overall Study
Withdrawal by Subject
8
3

Baseline Characteristics

Effect of Increased Light Exposure on Fatigue in Breast Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Effect of Bright Light
n=23 Participants
Effect of bright light on fatigue in women with breast cancer
Effect of Red Light
n=16 Participants
effect of red light on fatigue in women with breast cancer
Total
n=39 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
19 Participants
n=5 Participants
15 Participants
n=7 Participants
34 Participants
n=5 Participants
Age, Categorical
>=65 years
4 Participants
n=5 Participants
1 Participants
n=7 Participants
5 Participants
n=5 Participants
Age, Continuous
54.3 years
STANDARD_DEVIATION 9 • n=5 Participants
53.5 years
STANDARD_DEVIATION 9 • n=7 Participants
53.9 years
STANDARD_DEVIATION 9 • n=5 Participants
Sex: Female, Male
Female
23 Participants
n=5 Participants
16 Participants
n=7 Participants
39 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
23 participants
n=5 Participants
16 participants
n=7 Participants
39 participants
n=5 Participants

PRIMARY outcome

Timeframe: four cycles of chemotherapy

Population: All participants that were randomized and began the protocol were included in analyses.

The Short Form of the Multidimensional Fatigue Symptom Inventory (MFSI-sf) was used to measure fatigue. The range of possible score for each subscale is 0 to 24, and the range for total score is -24 to 96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where larger score indicates less fatigue.

Outcome measures

Outcome measures
Measure
Effect of Bright Light
n=23 Participants
Effect of bright light on fatigue in women with breast cancer
Effect of Red Light
n=16 Participants
effect of red light on fatigue in women with breast cancer
Fatigue
15.25 units on a scale
Standard Error 5.5
21.6 units on a scale
Standard Error 7.2

Adverse Events

Effect of Bright Light

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Effect of Red Light

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Sonia Ancoli-Israel

UCSD

Phone: 858 642-7710

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place